Revance revealed two peer-reviewed papers on its Daxxify wrinkle therapy within the Aesthetic Surgical procedure Journal.
The publications spotlight the nuances of glabellar line (GL) injection method and intention to enhance affected person outcomes, regardless of the neuromodulator used.
The primary publication, Influence of Glabellar Injection Approach with DaxibotulinumtoxinA for Injection on Forehead Place, demonstrates the affect of refined variations in glabellar line injection method on eyebrow place.
The second paper, Integrative Evaluation for Optimizing Aesthetic Outcomes When Treating Glabellar Strains with Botulinum Toxin Kind A: An Appreciation of the Function Of The Frontalis, proposes a structured and complete evaluation algorithm targeted on anatomical rules, permitting for an individualized therapy method.
“These newly revealed manuscripts show Revance’s dedication to enhancing aesthetic affected person outcomes,” mentioned Conor Gallagher, vice chairman of medical affairs and scientific innovation at Revance. “We present for the primary time, with supporting knowledge, that small variations in glabellar line method can affect each static and dynamic forehead place outcomes. Though glabellar line therapy is usually thought-about easy, secondary results on eyebrow place can affect the broader aesthetic consequence, past the straightforward discount of the frown traces.”
Daxxify (DaxibotulinumtoxinA-lanm) for injection is an FDA-approved long-lasting peptide-formulated neuromodulator product to be used in adults for the short-term enchancment of reasonable to extreme frown traces.
It will probably ship outcomes that last as long as a 12 months for sufferers with probably solely two remedies per 12 months and has been proven to be efficient, typically protected, and effectively tolerated, in accordance with Revance. Daxxify is powered by a cell-penetrating peptide know-how (Peptide Alternate Know-how), Revance’s proprietary, artificial, 35-amino-acid stabilizing excipient with a extremely constructive cost, and is freed from human serum albumin or animal-based parts.